drugset / Trial / NCT05486598

A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects

NCT05486598

Phase 1 Unknown 16 enrolled Advenchen Laboratories, LLC
RandomizedCrossoverOpen-labelTreatment

Summary

Main study objective: the pharmacokinetic effects of high-fat diet on AL8326 after oral administration of AL8326 tablets in Chinese healthy adult subjects. Secondary study objectives: safety and tolerability of a single oral dose of AL8326 tablets in healthy subjects

Timeline

Start
2022-06-21
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AL8326 Unknown Oral

Indications

No indication recorded.